1.
Strauss JS, Pochi PE, Downing DT: Acne: perspectives.J Invest Dermatol 1974, 62:321-325.
2.
Oberemok SS, Shalita AR: Acne vulgaris, I: pathogenesis and diagnosis.Cutis 2002, 70:101-105.
3.
Aktan S, Ozmen E, Sanli B: Anxiety, Depression, and Nature of Acne Vulgaris in Adolescents.Int J Dermatol 2000, 39:354-357.
4.
Vowels BR, Yang S, Leyden JJ: Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne.Infect Immun 1995, 63:3158-3165.
5.
Graham GM, Farrar MD, Cruse-Sawyer JE, Holland KT, Ingham E: Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL.Br J Dermatol 2004, 150:421-428.
6.
Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ, Brightbill HD, Holland D, Cunliffe WJ, Akira S, Sieling PA, Godowski PJ, Modlin RL: Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses.J Immunol 2002, 169:1535-1541.
7.
Nagy I, Pivarcsi A, Koreck A, Szell M, Urban E, Kemeny L: Distinct strains of Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors.J Invest Dermatol 2005, 124:931-938.
8.
Jugeau S, Tenaud I, Knol AC, Jarrousse V, Quereux G, Khammari A, Dreno B Jugeau S, Tenaud I, Knol AC, Jarrousse V, Quereux G, Khammari A, Dreno B: Induction of toll-like receptors by Propionibacterium acnes.Br J Dermatol 2005, 153:1105-13.
9.
Schröder JM, Christophers E: Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells.J Immunol 1989, 142:244-251.
10.
Kim J: Review of the Innate Immune Response in Acne vulgaris: Activation of Toll-Like Receptor 2 in Acne Triggers Inflammatory Cytokine Responses.Dermatology 2005, 211:193-198.
11.
Trivedi NR, Gilliland KL, Zhao W, Liu W, Thiboutot DM: Gene array expression profiling in acne lesions reveals marked upregulation of genes involved in inflammation and matrix remodeling.J Invest Dermatol 2006, 126:1071-1079.
12.
Pochi PE, Shalia AR, Strauss JS, Webster SB, Cunliffe WJ, Katz HI: Report of the consensus conference on acne classification.J Am Acad Dermatol 1991, 24:495-500.
13.
Gollnick HP, Zouboulis CC, Akamatsu H, Kurokawa I, Schulte A: Pathogenesis and pathogenesis related treatment of acne.J Dermatol 1991, 18:489-499.
14.
Holmes RL, Williams M, Cunliffe WJ: Pilo-sebaceous duct obstruction and acne.Br J Dermatol 1972, 87:327-332.
15.
Sticherling M, Bornscheuer E, Schroder JM, Christophers E: Localization of neutrophil-activating peptide-1/interleukin-8-immunoreactivity in normal and psoriatic skin.J Invest Dermatol 1991, 96:26-30.
16.
Li A, Dubey S, Varney ML, Dave BJ, Singh RK: IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis.J Immunol 2003, 170:3369-3376.
17.
Gillitzer R, Berger R, Mielke V, Muller C, Wolff K, Stingl G: Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ.J Invest Dermatol 1991, 97:73-79.
18.
Beaubien BC, Collins PD, Jose PJ, Totty NF, Hsuan J, Waterfield MD, Williams TJ: A novel neutrophil chemoattractant generated during an inflammatory reaction in the rabbit peritoneal cavity in vivo. Purification, partial amino acid sequence and structural relationship to interleukin 8.Biochem J 1990, 271:797-801.
19.
Collins PD, Jose PJ, Williams TJ: The sequential generation of neutrophil chemoattractant proteins in acute inflammation in the rabbit in vivo. Relationship between C5a and proteins with the characteristics of IL-8/neutrophil-activating protein 1.J Immunol 1991, 146:677-684.
20.
Wiedow O, Meyer-Hoffert U: Neutrophil serine proteases: potential key regulators of cell signalling during inflammation.J Intern Med 2005, 257:319-328.
21.
Anttila HS, Reitamo S, Erkko P, Ceska M, Moser B, Baggiolini M: Interleukin-8 immunoreactivity in the skin of healthy subjects and patients with palmoplantar pustulosis and psoriasis.J Invest Dermatol 1992, 98:96-101.